isoflurophate has been researched along with Weight Loss in 2 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rojas, A | 1 |
| McCarren, HS | 1 |
| Wang, J | 1 |
| Wang, W | 1 |
| Abreu-Melon, J | 1 |
| Wang, S | 1 |
| McDonough, JH | 1 |
| Dingledine, R | 1 |
| Nagy, A | 1 |
| Plonowski, A | 1 |
| Schally, AV | 1 |
2 other studies available for isoflurophate and Weight Loss
| Article | Year |
|---|---|
Comparison of neuropathology in rats following status epilepticus induced by diisopropylfluorophosphate and soman.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Waves; Cell Death; Cyclooxygenase 2; Disease Models, Anim | 2021 |
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
Topics: Adult; Animals; Antineoplastic Agents; Bombesin; Carboxylesterase; Carboxylic Ester Hydrolases; Chol | 2000 |